Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
ConclusionPoor PS, short period of time since the previous treatment, and more than one metastatic location were associated with poorer prognostic.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Biochemistry | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Liver | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Urology & Nephrology